Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Synergy Pharmaceuticals 

6334 Winfield Boulevard

Margate  Florida  33063  U.S.A.
Phone: 954-801-3950 Fax: n/a



 Company News
Synergy Pharmaceuticals Reports Second Quarter And First Half 2014 Financial Results 8/12/2014 8:35:41 AM
Synergy Pharmaceuticals To Present At Canaccord Genuity Growth Conference 8/6/2014 9:19:59 AM
Synergy Pharmaceuticals Completes Patient Enrollment For Its SP-333 Phase 2 Trial In Patients With Opioid-Induced Constipation 7/17/2014 10:56:29 AM
Synergy Pharmaceuticals Reaches Halfway Mark For The First Pivotal Phase 3 Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation 7/14/2014 11:29:06 AM
Synergy Pharmaceuticals Announces Successful End-Of-Phase 2 Meeting With FDA For Plecanatide In Irritable Bowel Syndrome With Constipation 7/8/2014 10:50:18 AM
Synergy Pharmaceuticals Appoints Paul Eng, Ph.D., As Senior Vice President, Drug Development 5/29/2014 7:31:40 AM
Synergy Pharmaceuticals’ Chairman And CEO, Dr. Gary S. Jacob, Awarded Honorary Degree By The University of Missouri – St. Louis 5/15/2014 9:19:18 AM
Synergy Pharmaceuticals To Present At 2014 UBS Global Healthcare Conference 5/14/2014 7:13:39 AM
Synergy Pharmaceuticals Reports First Quarter 2014 Financial Results: Cash And Investments Increase To $70.6 Million As Of March 31, 2014 5/13/2014 7:14:53 AM
Synergy Pharmaceuticals To Give Plenary Presentation At The 16th Annual TIDES Summit 5/12/2014 10:01:08 AM